poisar

Filings · News reference

Zenas BioPharma Registers Resale Of Up To 7M Shares By Selling Stocholder

Benzinga Newsdesk

ZENAS BIOPHARMA, INC.Up to 7,000,000 Shares of Common Stock​This prospectus relates to the resale or other disposition from time to time of up to 7,000,000 shares (the "Shares") of our common stock, par value

More filings newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ZBIO
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Na

    Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Zenas BioPharma announced on September 15, 2026, that its Compensation Committee granted inducement stock options to purchase 53,700 shares and 98,900 restricted stock units to newly hired employees. The stock options have a 10-year term with an exercise price of $31.93 per share and vest over four years, while RSUs vest equally over four years through 2030.

    ZBIO